Biomarker Research embodies our transition towards scientific excellence. This crucial phase develops the foundations of tomorrow's medical AI through revolutionary participatory research programs, ensuring objective and reliable health data.
with our new toxicological analyses - hair matrix
Analyses intended for patients without declared pathology establishing normative references for tomorrow's predictive AI.
Opening end of August 2025
Participatory research to analyze 52 metals by ICP-MS spectrometry and identify contamination biomarkers (intoxication, implantation and explantation)
First study on a potential co-diagnostic toxicological biomarker associated with electromagnetic field intolerance.
Opening end of August 2025
Scientific excellence requires a methodical approach. Our progressive opening strategy allows for controlled scaling, ensuring deep expertise on each chronic pathology. Regularly, a new program joins our research ecosystem.
Upcoming programs: Fibromyalgia, Alzheimer's, Neuroatypicalities